Showing results (81-90 of 130) with videos related to

Sort By:
Pageof 13
Patient Preference and Adherence|August 16, 2016
Evaluating preferences for profiles of glucagon-like peptide-1 receptor agonists among injection-naive type 2 diabetes patients in JapanHeather L Gelhorn, Elizabeth D Bacci, Jiat Ling Poon, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|March 13, 2010
Utilities and disutilities for attributes of injectable treatments for type 2 diabetesKristina S Boye, Louis S Matza, Kimberly N Walter, et al.
Patient Preference and Adherence|December 5, 2015
Evaluating preferences for profiles of GLP-1 receptor agonists among injection-naïve type 2 diabetes patients in the UKHeather L Gelhorn, Jiat-Ling Poon, Evan W Davies, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|May 17, 2014
Challenges to time trade-off utility assessment methods: when should you consider alternative approaches?Kristina S Boye, Louis S Matza, David H Feeny, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 18, 2010
A valuation of infusion therapy to preserve islet function in type 1 diabetesAndrew Lloyd, Paul Swinburn, Kristina S Boye, et al.
Value in Health Regional Issues|November 25, 2016
Utilities for Type 2 Diabetes Treatment-Related Attributes in a South Korean and Taiwanese PopulationNarayan Rajan, Kristina S Boye, Meaghan Gibbs, et al.
Journal of Medical Economics|January 29, 2015
Economic impact of severe and non-severe hypoglycemia in patients with Type 1 and Type 2 diabetes in the United StatesVolker Foos, Nebibe Varol, Bradley H Curtis, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2008
A modeled economic evaluation comparing atomoxetine with stimulant therapy in the treatment of children with attention-deficit/hyperactivity disorder in the United KingdomSuzi Cottrell, Dominic Tilden, Paul Robinson, et al.
Current Medical Research and Opinion|January 26, 2016
Physician perceptions of GLP-1 receptor agonists in the UKLouis S Matza, Sarah E Curtis, Jessica B Jordan, et al.
Patient Preference and Adherence|March 29, 2023
The Impact of Substantial Improvements in HbA1c and Weight Loss on the Medication Preferences of People with Type 2 DiabetesHeather L Gelhorn, Beatrice Osumili, Katelyn Brown, et al.
Pageof 13